Hutchmed (HCM) reported 2024 earnings Wednesday of $0.22 per diluted American depositary share, down from $0.58 a year earlier.
Three analysts polled by FactSet expected $0.27.
Revenue for the year ended Dec. 31 was $630.2 million, down from $838 million a year earlier.
Analysts surveyed by FactSet expected $665.9 million.
The company said it had $836.1 million in cash, cash equivalents and short-term investments as of Dec. 31.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。